Country | Source | Date | Status Change | Sex | Age group | ||
---|---|---|---|---|---|---|---|
<50 | 50–69 (95%CI) | 70+ (95%CI) | |||||
CDC | 16.05.2020 | Infection to death | Both | Ref | 9.8 (9.5–10.2) | 53.1 (51.3–54.9) | |
Italy [37] | ISS | 20.05.2020 | Infection to death | Male | Ref | 10.1 (8.9–11.4) | 43.2 (38.2–49.0) |
Female | Ref | 11.1 (9.0–13.7) | 82.3 (67.4–100.4) | ||||
Both | Ref | 11.3 (10.1–12.6) | 53.8 (48.5–59.8) | ||||
Spain [38] | ISCIII | 21.05.2020 | Infection to hospitalisation | Male | Ref | 1.9 (1.8–1.9) | 2.2 (2.2–2.3) |
Female | Ref | 2.2 (2.1–2.2) | 3.0 (2.9–3.0) | ||||
Both | Ref | 2.1 (2.1–2.1) | 2.6 (2.6–2.7) | ||||
Hospitalisation to death | Male | Ref | 3.7 (3.2–4.2) | 15.8 (13.7–18.1) | |||
Female | Ref | 4.1 (0.6–28.6) | 26.8 (3.8–187.9) | ||||
Both | Ref | 3.7 (3.3–4.1) | 18.1 (16.2–20.2) | ||||
Infection to death | Male | Ref | 6.9 (6.0–8.0) | 35.3 (30.7–40.6) | |||
Female | Ref | 7.5 (6.1–9.1) | 66.1 (54.8–79.8) | ||||
Both | Ref | 7.7 (6.9–8.7) | 47.3 (42.3–52.8) | ||||
France [39] | Santé publique France | 18.05.2020 | Hospitalisation to death | Both | Ref | 2.8 (2.6–3.1) | 7.3 (6.7–7.9) |
England [40] | Public Health England | 20.05.2020 | Infection to death | Male | Ref | 7.2 (6.5–7.9) | 19.0 (17.3–20.8) |
Female | Ref | 9.3 (8.2–10.5) | 36.2 (32.3–40.7) | ||||
Both | Ref | 8.7 (8.1–9.4) | 26.6 (24.8–28.6) | ||||
Belgium [41] | Sciensano | 26.05.2020 | Infection to death | Male | Ref | 5.0 (4.0–6.2) | 20.2 (16.5–24.7) |
Female | Ref | 9.1 (6.8–12.3) | 51.7 (39.3–68.1) | ||||
Both | Ref | 7.4 (6.2–8.8) | 32.0 (27.2–37.7) | ||||
Germany [42] | RKI | 27.05.2020 | Infection to death | Both | Ref | 17.5 (14.2–21.6) | 195.1 (159.6–238.5) |